• 6900 Citations
  • 43 h-Index
1988 …2019
If you made any changes in Pure these will be visible here soon.

Research Output 1988 2019

Filter
Editorial
2018
Coinfection
Hepacivirus
Antiviral Agents
Clinical Trials
HIV
1 Citation (Scopus)

Staging for hepatocellular carcinoma in light of tumor heterogeneity: Time to change or update?

Kim, D. Y. & Han, K. H., 2018 Jun, In : Hepatology. 67, 6, p. 2076-2078 3 p.

Research output: Contribution to journalEditorial

Hepatocellular Carcinoma
Neoplasms
2017

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?

Kim, D. Y., 2017 Jun 1, In : Clinical and Molecular Hepatology. 23, 2, p. 123-124 2 p.

Research output: Contribution to journalEditorial

Open Access
Phenylurea Compounds
Antineoplastic Combined Chemotherapy Protocols
Intra Arterial Infusions
Liver Neoplasms
Hepatocellular Carcinoma
1 Citation (Scopus)

Estimation of direct medical costs related to chronic hepatitis C: A rationale for early antiviral therapy

Kim, D. Y., 2017 Nov, In : Gut and liver. 11, 6, p. 745-746 2 p.

Research output: Contribution to journalEditorial

Ribavirin
Chronic Hepatitis C
Secondary Prevention
Combination Drug Therapy
Antiviral Agents
2014

Hepatitis C viral kinetics as a determinant of stopping pegylated interferon and ribavirin in genotype 1 infection

Kim, D. Y., 2014 Jul, In : Gut and liver. 8, 4, p. 335-336 2 p.

Research output: Contribution to journalEditorial

Ribavirin
Chronic Hepatitis C
Hepatitis C
Recombinant Proteins
Interferon-alpha
2011
Hepatocellular Carcinoma
sorafenib